ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia

References

• Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol 2000;7:223–234.
   PubMed Web of Science ®Google Scholar
• Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446–5456.
   PubMed Web of Science ®Google Scholar
• Moreno C, Montserrat E. New prognostic markers in chronic lymphocytic leukemia. Blood Rev 2008;22:211–219.
   PubMed Web of Science ®Google Scholar
• Jaksic B, Vitale B. Total tumour mass score (TTM): a new parameter in chronic lymphocyte leukaemia. Br J Haematol 1981;49:405–413.
   PubMed Web of Science ®Google Scholar
• Matutes E, Polliack A. Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Clin Exp Hematol 2000;4:22–47.
   PubMedGoogle Scholar
• Amouroux I, Mossafa H, Gentilhomme O, et al. Chronic lymphocytic leukaemia with binucleated lymphocytes. Leuk Lymphoma 1997;27:533–537.
   PubMed Web of Science ®Google Scholar
• Wierda WG, Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol 1999;6:253–261.
   PubMedGoogle Scholar
• Montserrat E. New prognostic markers in CLL. Hematology Am Soc Hematol Educ Program 2006:279–284.
   PubMedGoogle Scholar
• Rassenti LZ, Huynh L, Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893–901.
   PubMed Web of Science ®Google Scholar
• Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003;101:4944–4951.
   PubMed Web of Science ®Google Scholar
• Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764–1775.
   PubMed Web of Science ®Google Scholar
• Chan AC, Iwashima M, Turck CW, et al. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 1992;71:649–662.
   PubMed Web of Science ®Google Scholar
• Wilhelm C, Neubauer A, Brendel C. Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different gating strategies are applied. Cytometry B Clin Cytom 2006;70: 242–250.
   PubMed Web of Science ®Google Scholar
• Kay S, Herishanu Y, Pick M, et al. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome. Cytometry B Clin Cytom 2006; 70:218–226.
   PubMed Web of Science ®Google Scholar
• Zanotti R, Ambrosetti A, Lestani M, et al. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. Leukemia 2007;21:102–109.
   PubMed Web of Science ®Google Scholar
• Vener C, Gianelli U, Cortelezzi A, et al. ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia. Leuk Lymphoma 2006;47:245–251.
   PubMed Web of Science ®Google Scholar
• Schade U, Bock O, Vornhusen S, et al. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70). Hum Pathol 2006;37:1153–1161.
   PubMed Web of Science ®Google Scholar
• Carreras J, Villamor N, Colomo L, et al. Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms. J Pathol 2005;205:507–513.
   PubMed Web of Science ®Google Scholar
• Sabattini E, Orduz R, Campidelli C, et al. B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimens. J Clin Pathol 2007;60:627–632.
   PubMed Web of Science ®Google Scholar
• Korac P, Ajdukovic R, Kardum Paro MM, et al. Immunohistochemical analysis of ZAP-70 expression in chronic lymphocytic leukemia. J Mol Histol 2009;40:81–86.
   PubMed Web of Science ®Google Scholar
• Del Principe MI, Del Poeta G, Buccisano F, et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 2006;108:853–861.
   PubMed Web of Science ®Google Scholar
• Orchard JA, Ibbotson RE, Davis Z, et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004;363: 105–111.
   PubMed Web of Science ®Google Scholar
• Chaar BT, Schergen AK, Grosso LE. Discordance of ZAP-70 in patients with chronic lymphocytic leukemia. Int J Lab Hematol 2008;30:36–40.
   PubMed Web of Science ®Google Scholar
• Sheridan R, Mounajjed T, Ehrmann DE, et al. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia. Cytometry B Clin Cytom 2006;70:320–321.
   PubMed Web of Science ®Google Scholar
• Admirand JH, Rassidakis GZ, Abruzzo LV, et al. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. Mod Pathol 2004;17:954–961.
   PubMed Web of Science ®Google Scholar
• Slack GW, Wizniak J, Dabbagh L, et al. Flow cytometric detection of ZAP-70 in chronic lymphocytic leukemia: correlation with immunocytochemistry and Western blot analysis. Arch Pathol Lab Med 2007;131:50–56.
   PubMed Web of Science ®Google Scholar
• Bojarska-Junak A, Rolinski J, Kawiak J. Modification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia. Folia Histochem Cytobiol 2005;43:19–23.
   PubMed Web of Science ®Google Scholar
• Chen L, Widhopf G, Huynh L, et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 2002;100:4609–4614.
   PubMed Web of Science ®Google Scholar
• Oscier DG, Matutes E, Copplestone A, et al. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol 1997;98: 934–939.
   PubMed Web of Science ®Google Scholar
• Bueso-Ramos CE, Ferrajoli A, Medeiros LJ, et al. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells. Hematology 2004;9:279–286.
   PubMedGoogle Scholar
• Ghia P, Strola G, Granziero L, et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol 2002;32:1403–1413.
   PubMed Web of Science ®Google Scholar
• Bennett F, Rawstron A, Plummer M, et al. B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle. Br J Haematol 2007;139:600–604.
   PubMed Web of Science ®Google Scholar
• Damle RN, Temburni S, Calissano C, et al. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood 2007;110:3352–3359.
   PubMed Web of Science ®Google Scholar
• Ruiz-Vela A, Piqueras R, Carvalho-Pinto C, et al. ZAP-70 upregulation in transformed B cells after early pre-BI cell transplant into NOD/SCID mice. Oncogene 2005;24:5119–5124.
   PubMed Web of Science ®Google Scholar